Drug search by name

Arikayce and Pulmonary disease

Result of checking the interaction of drug Arikayce and disease Pulmonary disease for safety when used together.

Check result:

Arikayce <> Pulmonary disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Higher frequency of exacerbations of underlying pulmonary disease has been reported with amikacin liposome treatment. Monitor closely patients with pulmonary impairment and treat as medically appropriate if this occurs during treatment with amikacin liposome. Pre- treatment with short-acting selective beta- 2 agonists should be considered for patients with known hyperreactive airway disease, chronic obstructive pulmonary disease, asthma, or bronchospasm.

Arikayce

Generic Name: amikacin liposome

Brand Name: Arikayce

Synonyms: n.a.

What is Arikayce?